Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy.

Pediatr Rheumatol Online J 2018 Aug 6;16(1):51. Epub 2018 Aug 6.

University Hospitals Bristol NHS Foundation Trust, Bristol, UK.

Background: There is a paucity of data on the ocular outcomes in paediatric non-infectious uveitis since the introduction of the biologic agents. The purpose of this study was to outline the clinical characteristics of children with non-infectious uveitis and determine the visual outcomes and ocular complication rates in the modern era.

Methods: Children with non-infectious uveitis from January 2011 to December 2015 were identified. Data was collected at baseline, 1, 3, 5, and 10 years post diagnosis. The incidence rates of visual impairment, structural ocular complications and surgical intervention were calculated. Using logistic regression the association between various baseline characteristics and later visual impairment was investigated.

Results: Of the 166 children, 60.2% (n = 100) had a systemic disease association. 72.9% (n = 121) children received methotrexate, 58 children progressed to a biologic. The incidence rates of visual acuity loss to > 0.3 LogMAR (6/12) and to ≥1.0 LogMAR (6/60) were 0.05/Eye Year (EY) and 0.01/EY, respectively. Visual outcomes in the Juvenile Idiopathic Arthritis associated Uveitis (JIA-U) and Idiopathic Uveitis cohorts were not statistically significant. Of the 293 affected eyes, posterior synechiae was the predominant complication on presentation, while cataract had the highest incidence rate (0.05/EY). On direct comparison, children with JIA-U were statistically significantly more likely to develop glaucoma while children with Idiopathic Uveitis were statistically significantly more likely to develop macular oedema.

Conclusion: One third of children received a biological therapy, reflecting increasing utilisation and importance of biological agents in the management of inflammatory conditions. Rates of visual impairment and ocular complications are an improvement on previously published data.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12969-018-0266-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080499PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
August 2018
34 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: SimonRStones
August 15, 2018, 7:43 pm EST
twitter
Twitter: ICANIreland
August 11, 2018, 3:53 pm EST
twitter
Twitter: EATC4Children
August 10, 2018, 10:02 am EST

Publication Analysis

Top Keywords

rates visual
12
visual impairment
12
non-infectious uveitis
12
children
8
visual outcomes
8
idiopathic uveitis
8
children received
8
statistically develop
8
children non-infectious
8
incidence rates
8
ocular complications
8
uveitis
7
visual
6
outcomes
4
association 729%
4
uveitis statistically
4
disease association
4
systemic disease
4
children idiopathic
4
received methotrexate
4

References

(Supplied by CrossRef)
Article in Acta Ophthalmol Scand
T Päivönsalo-Hietanen et al.
Acta Ophthalmol Scand 2000
Article in Int Ophthalmol Clin
M Zierhut et al.
Int Ophthalmol Clin 2005
Article in Ophthalmology
JA Smith et al.
Ophthalmology 2009
Article in Br J. Ophthalmol
J de Boer et al.
Br J. Ophthalmol 2003
Article in Br J Ophthalmol
YM Hettinga et al.
Br J Ophthalmol 2015
Article in Ocul Immunol Inflamm
MP Paroli et al.
Ocul Immunol Inflamm 2009
Article in Ophthalmology
LI Kump et al.
Ophthalmology 2005
Article in Am J Ophthalmol
C Edelsten et al.
Am J Ophthalmol 2003
Article in Ophthalmology
I Tugal-Tutkun et al.
Ophthalmology 1996
Article in Am J Ophthalmol
JE Thorne et al.
Am J Ophthalmol 2007
Article in Ophthalmology
JE Thorne et al.
Ophthalmology 2010

Similar Publications